Abstract
Adoptive transfer of activated macrophages, being both effector cells and antigen-presenting cells, represents a promising approach to immunotherapy of cancer. In order to get activated macrophages with increased antitumor potential, in the present study, murine peritoneal macrophages were transduced with human macrophage colony-stimulating factor (M-CSF) and murine interferon-γ (IFNγ) by recombinant adenovirus infection. The results demonstrate that M-CSF and IFNγ gene-modified macrophages exhibited higher expression of MHC-II, B7.1 and ICAM-1, increased antigen-presenting activity and cytotoxicity. It was also shown that they secreted more tumor necrosis factor, interleukin-1 and nitric oxide. In vivo experiments showed that in previously initiated murine pulmonary metastatic melanoma, tumor lysate-pulsed, M-CSF and IFNγ gene-modified macrophages elicited more potent antitumor effects than tumor lysate pulsed M-CSF or IFNγ gene-modified macrophages. Cytotoxic T lymphocyte (CTL) activity, IFNγ and tumor-necrosis factor production of the splenocytes increased significantly in mice after intravenous injection of the gene-modified macrophages. M-CSF and IFNγ gene-modified macrophages may act as activated effector and antigen-presenting cells, thus eliciting a more potent antitumor response.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yoshida R, Yoneda Y, Kuriyama M, Kubota T . IFNγ- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment J Immunol 1999 163: 148–154
Andreesen R, Hennemann B, Krause SW . Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status, and perspectives J Leukoc Biol 1998 64: 419–426
Killion JJ, Fidler IJ . Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators Pharmacol Ther 1998 78: 141–154
Schuler G, Steinman RM . Dendritic cells as adjuvants for immune-mediated resistance to tumors J Exp Med 1997 186: 1183–1187
Celluzzi CM, Falo LD Jr . Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection J Immunol 1998 160: 3081–3085
Ashley DM et al. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors J Exp Med 1997 186: 1177–1782
Banchereau J, Steinman RM . Dendritic cells and the control of immunity Nature 1998 392: 245–252
Yoshioka H et al. Transformation of rat glioma cells with the M-CSF gene inhibits tumorigenesis in vivo J Neuro-oncol 1998 40: 197–204
Sakurai T et al. Effect of macrophage colony-stimulating factor (M-CSF) on mouse immune responses in vivo Immunopharmacol Immunotoxicol 1998 20: 79–102
Fixe P, Praloran V . M-CSF: haematopoietic growth factor or inflammatory cytokine? Cytokine 1998 10: 32–37
Heike Y et al. M-CSF gene transduction in multidrug-resistant human cancer cells to enhance anti-P-glycoprotein antibody-dependent macrophage-mediated cytotoxicity Int J Cancer 1993 54: 851–857
Wolff DJ, Gribin BJ . Interferon-gamma-inducible murine macrophage nitric oxide synthase: studies on the mechanism of inhibition by imidazole agents Arch Biochem Biophys 1994 311: 293–299
Martin JH, Edwards SW . Interferon-gamma enhances monocyte cytotoxicity via enhanced reactive oxygen intermediate production. Absence of an effect on macrophage cytotoxicity is due to failure to enhance reactive nitrogen intermediate production Immunology 1994 81: 592–597
Marodi L et al. Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors J Clin Invest 1993 91: 2596–2601
Goldberg M, Belkowski LS, Bloom BR . Regulation of macrophage growth and antiviral activity by interferon-gamma J Cell Biol 1989 109: 1331–1340
Fruh K, Yang Y . Antigen presentation by MHC class I and its regulation by interferon gamma Curr Opin Immunol 1999 11: 76–81
Billiau A, Heremans H, Vermeire K, Matthys P . Immunomodulatory properties of interferon-gamma. An update Ann NY Acad Sci 1998 856: 22–32
Korbelik M, Naraparaju VR, Yamamoto N . Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer Br J Cancer 1997 75: 202–207
Kimball ES, Kovacs E, Clark MC, Schneider CR . Activation of cytokine production and adhesion molecule expression on THP-1 myelomonocytic cells by macrophage colony-stimulating factor in combination with interferon-gamma J Leukoc Biol 1995 58: 585–594
Morse MA et al. Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen Clin Cancer Res 1999 5: 1331–1338
Parmiani G, Colombo MP, Melani C, Arienti F . Cytokine gene transduction in the immunotherapy of cancer Adv Pharmacol 1997 40: 259–307
Pardoll DM . Cancer vaccines Nature Med 1999 4: 525–531
Ballow M, Nelson R . Immunopharmacology: immunomodulation and immunotherapy JAMA 1997 278: 2008–2017
Alleva DG, Burger CJ, Elgert KD . Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2 J Immunol 1994 153: 1674–1686
Aoe T, Okamoto Y, Saito T . Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex J Exp Med 1995 181: 1881–1886
Dullens HF, Den Otter W . Therapy with allogeneic immune peritoneal cells Cancer Res 1974 34: 1726–1730
Hennemann B et al. Phase I trial of adoptive immunotherapy of cancer patients using monocyte-derived macrophages activated with interferon gamma and lipopolysaccharide Cancer Immunol Immunother 1998 45: 250–256
Eymard JC et al. Phase I/II trial of autologous activated macrophages in advanced colorectal cancer Eur J Cancer 1996 32: 1905–1911
Dorsch M et al. Macrophage colony-stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppression Eur J Immunol 1993 23: 186–190
Abe J et al. Antitumor effect induced by granulocyte/macrophage colony-stimulating factor gene-modified tumor vaccination comparison of adenovirus- and retrovirus-mediated genetic transduction J Cancer Res Clin Oncol 1995 121: 587–593
Kanai F et al. In vivo gene therapy for alpha fetoprotein producing hepatocellular carcinoma by adenovirus mediated transfer of cytosine deaminase gene Cancer Res 1997 57: 461–465
Ju DW, Cao X, Arces B . Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a murine melanoma model Cancer Gene Ther 1997 4: 139–144
Ju DW, Wang BM, Cao X . Adenovirus-mediated combined suicide gene and interleukin-2 gene therapy for the treatment of established tumor and induction of antitumor immunity J Cancer Res Clin Oncol 1998 124: 683–689
Cao X et al. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity J Immunol 1998 161: 6238–6244
Cao X et al. Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice Gene Therapy 1998 5: 1130–1136
Abe K et al. Early-appearing tumor-infiltrating natural killer cells play an important role in the nitric oxide production of tumor-associated macrophages through their interferon production Cancer Immunol Immunother 1998 45: 225–233
Acknowledgements
This work was supported by National Natural Science Foundation of China (39825123, 39780025).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lei, H., Ju, D., Yu, Y. et al. Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophage colony-stimulating factor and interferon-γ. Gene Ther 7, 707–713 (2000). https://doi.org/10.1038/sj.gt.3301162
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301162
Keywords
This article is cited by
-
Glucocorticoids suppress cystathionine gamma-lyase expression and H2S production in lipopolysaccharide-treated macrophages
Cellular and Molecular Life Sciences (2010)
-
Extracellular accumulation of recombinant proteins fused to the carrier protein YebF in Escherichia coli
Nature Biotechnology (2006)
-
Intratumoral injection of interferon-gamma gene-modified dendritic cells elicits potent antitumor effects: effective induction of tumor-specific CD8+ CTL response
Journal of Cancer Research and Clinical Oncology (2005)
-
Picolinic acid- or desferrioxamine-inducible autocrine activation of macrophages engineered to produce IFNγ: an approach for gene therapy
Gene Therapy (2004)
-
Generation of high-titer retroviral vector-producing macrophages as vehicles for in vivo gene transfer
Gene Therapy (2001)